Search

everythinglearnresearchcommunity

for

Search:↓

Vitiligo causes white skin patches and can lead to psychological stress.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Both treatments for alopecia areata showed similar modest effectiveness.

HFMs can help study hair growth and test potential hair growth drugs.

The document concludes that proper diagnosis and treatment of common scalp disorders are important for both physical and psychological health.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Prolactin may be important for skin growth and immune function.

Hormonal therapies are safe and effective for treating adult women's acne.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Punctate follicular porokeratosis is a skin condition with specific features seen in hair follicles.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.